Metformin in chemically-induced mammary carcinogenesis in rats

作者: B. Bojkova , P. Orendas , M. Garajova , M. Kassayova , V. Kutna

DOI: 10.4149/NEO_2009_03_269

关键词:

摘要: In this paper the chemopreventive effect of peroral antidiabetic metformin in mammary carcinogenesis female Sprague-Dawley rats was evaluated. Mammary induced by N-methyl-N-nitrosourea (NMU) administered two intraperitoneal doses each per 50 mg/kg b.w. between 43.-55. postnatal days. Metformin drinking water (at a concentration microg/ml and 500 microg/ml) 13 days before first NMU dose until termination experiment. During experiment animals were weekly weighed palpated for presence tumors, incidence, latency, tumor frequency, volume recorded. The terminated 18 weeks after dose, basic growth parameters metabolic hormonal variables did not significantly alter although delay onset recorded higher dose. altered variables. Insulinemia decreased both comparison with intact without changes glycemia, triacylglycerols liver increased serum when compared to intacts. Higher attenuated lipoperoxidation liver.

参考文章(33)
Albert Zlatkis, Albert Zlatkis, Albert J. Boyle, Albert J. Boyle, Bennie Zak, Bennie Zak, A new method for the direct determination of serum cholesterol. Journal of Laboratory and Clinical Medicine. ,vol. 41, pp. 486- 492 ,(1953) , 10.5555/URI:PII:0022214353901255
Susan E. Hankinson, Eva S. Schernhammer, Insulin-like growth factor and breast cancer risk: evidence from observational studies. Breast disease. ,vol. 17, pp. 27- 40 ,(2003) , 10.3233/BD-2003-17104
Patrice Faure, Nicolas Wiernsperger, Camille Polge, Alain Favier, Serge Halimi, Impairment of the antioxidant properties of serum albumin in patients with diabetes: protective effects of metformin. Clinical Science. ,vol. 114, pp. 251- 256 ,(2008) , 10.1042/CS20070276
Kathryn N. Phoenix, Frank Vumbaca, Kevin P. Claffey, Therapeutic Metformin/AMPK Activation Promotes the Angiogenic Phenotype in the ERα Negative MDA-MB-435 Breast Cancer Model Breast Cancer Research and Treatment. ,vol. 113, pp. 101- 111 ,(2009) , 10.1007/S10549-008-9916-5
V.M. Dilman, L.M. Berstein, M.N. Ostroumova, S.N. Fedorov, T.E. Poroshina, E.V. Tsyrlina, V.P. Buslaeva, V.F. Semiglazov, I.K. Seleznev, Yu.F. Bobrov, I.A. Vasilyeva, V.B. Kondratjev, V.S. Nemirovsky, Y.F. Nikiforov, Metabolic Immunodepression and Metabolic Immunotherapy Oncology. ,vol. 39, pp. 13- 19 ,(1982) , 10.1159/000225596
Walter H. Gotlieb, Julio Saumet, Marie-Claude Beauchamp, Jing Gu, Susie Lau, Michael N. Pollak, Ilan Bruchim, In vitro metformin anti-neoplastic activity in epithelial ovarian cancer. Gynecologic Oncology. ,vol. 110, pp. 246- 250 ,(2008) , 10.1016/J.YGYNO.2008.04.008
Vladimir N Anisimov, Lev M Berstein, Irina G Popovich, Mark A Zabezhinski, Peter A Egormin, Margarita L Tyndyk, Ivan V Anikin, Anna V Semenchenko, Anatoli I Yashin, Central and peripheral effects of insulin/IGF-1 signaling in aging and cancer: antidiabetic drugs as geroprotectors and anticarcinogens. Annals of the New York Academy of Sciences. ,vol. 1057, pp. 220- 234 ,(2005) , 10.1196/ANNALS.1356.017
A. L. Crown, K. Cottle, S. L. Lightman, S. Falk, V. Mohamed-Ali, L. Armstrong, A. B. Millar, J. M. P. Holly, What is the role of the insulin-like growth factor system in the pathophysiology of cancer cachexia, and how is it regulated? Clinical Endocrinology. ,vol. 56, pp. 723- 733 ,(2002) , 10.1046/J.1365-2265.2002.01540.X
Joseph H. Roe, Robert E. Dailey, Determination of glycogen with the anthrone reagent Analytical Biochemistry. ,vol. 15, pp. 245- 250 ,(1966) , 10.1016/0003-2697(66)90028-5
Josie M M Evans, Louise A Donnelly, Alistair M Emslie-Smith, Dario R Alessi, Andrew D Morris, Metformin and reduced risk of cancer in diabetic patients BMJ. ,vol. 330, pp. 1304- 1305 ,(2005) , 10.1136/BMJ.38415.708634.F7